Abstract
Renal angiomyolipomas (AML) are benign tumors that can grow to considerable size and cause life-threatening hemorrhage. Selective arterial embolization (SAE) is a minimally invasive treatment to devascularize and shrink AMLs. Post-procedural systemic hypertension has not been previously described as a risk of the procedure. Our providers diagnosed post-procedural hypertension in several patients following SAE and sought to determine the incidence in our patient population.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
